Dexcom Inc. Stock
Price
Target price
€61.54
€61.54
0.780%
0.48
0.780%
€79.69
02.02.26 / Tradegate
WKN: A0D9T1 / Symbol: DXCM / Name: DexCom / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Dexcom Inc. Stock
Dexcom Inc. gained 0.780% compared to yesterday.
The stock is one of the favorites of our community with 39 Buy predictions and 1 Sell predictions.
With a target price of 79 € there is a positive potential of 28.37% for Dexcom Inc. compared to the current price of 61.54 €.
Our community identified positive and negative aspects for Dexcom Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Dexcom Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Dexcom Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | 0.780% | -0.308% | 8.364% | -26.458% | 7.362% | -37.845% | -24.905% |
| Baxter International | -0.770% | 1.898% | 1.298% | -46.310% | 3.462% | -60.873% | -73.493% |
| Dentsply Sirona Inc. | 0.000% | -3.132% | 7.760% | -45.603% | 8.029% | -71.495% | -77.143% |
| Teleflex Inc. | -0.570% | -0.571% | -16.346% | -49.419% | -14.706% | -61.161% | -71.935% |
Comments
DexCom (NASDAQ:DXCM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom (NASDAQ:DXCM) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating. They now have a $71.00 price target on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom (NASDAQ:DXCM) had its price target raised by analysts at Mizuho from $75.00 to $78.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
News
DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price?
It's been a tough year for DexCom (NASDAQ: DXCM), whose stock price is down 25% since the start of 2025. It's a surprising performance, given that the overall stock market has been doing well; you
1 Spectacular Growth Stock Down 20% to Buy Right Now, According to Wall Street
Since last year, DexCom (NASDAQ: DXCM) has faced a series of issues that have sunk its stock price. The medical device specialist's shares are down 20% over the trailing-12-month period and are
From Dividends to Growth: Why These 3 Stocks Stand Out in 2025
It's rare for an attractive dividend stock also to have growth potential. Most leading dividend distributors have moved past their high-growth days and have transitioned into stable, mature
